Upload
Featured Recent Articles Topics Login Upload

Search Results for ''

published presentations and documents on DocSlides.

Idiopatische Lungenfibrose IPF
Idiopatische Lungenfibrose IPF
by nersonvisa
IPF. S2k-Leitline basiert. Präsentation im Rahmen...
IPF SUBSETS Venerino Poletti
IPF SUBSETS Venerino Poletti
by brown
Department. of . Diseases. of the . Thorax. , Os...
Clinical Approaches to IPF:
Clinical Approaches to IPF:
by lindy-dunigan
Diagnosis and Monitoring. Kevin R. Flaherty, MD, ...
NAVIGATING the NEW ERA in IPF:
NAVIGATING the NEW ERA in IPF:
by faustina-dinatale
Comorbidities and Complications. FACULTY. Title. ...
Idiopathic pulmonary fibrosis (IPF)
Idiopathic pulmonary fibrosis (IPF)
by danika-pritchard
– . The need for early recognition and referral...
Idiopathic pulmonary fibrosis (IPF)
Idiopathic pulmonary fibrosis (IPF)
by min-jolicoeur
– . The need for early recognition and referral...
A NEW ERA in IPF: Trials and Treatments
A NEW ERA in IPF: Trials and Treatments
by celsa-spraggs
Educational Activity Learning Objective. Upon com...
PRECISION MEDICINE FOR IPF: DREAM OR REALITY?
PRECISION MEDICINE FOR IPF: DREAM OR REALITY?
by calandra-battersby
IMRE NOTH, MD. CLINICAL CARE: NEW AND EVOLVING TR...
IPF Diagnostic Methods and Differential Diagnosis
IPF Diagnostic Methods and Differential Diagnosis
by conchita-marotz
. Content. Importance. . of. . early. . diagn...
NAVIGATING the NEW ERA in IPF:
NAVIGATING the NEW ERA in IPF:
by sherrill-nordquist
Diagnosing Idiopathic Pulmonary Fibrosis. FACULTY...
Case 1: Familial IPF Case Presentation: Familial IPF
Case 1: Familial IPF Case Presentation: Familial IPF
by luanne-stotts
56-year-old Hispanic female with a family history...
Breakthroughs in IPF Management:
Breakthroughs in IPF Management:
by sherrill-nordquist
The . Next Steps in Individualizing Treatment. Le...
VINCENT COTTIN, MD, PhD
VINCENT COTTIN, MD, PhD
by sherrill-nordquist
PULMONARY FIBROSIS MANAGEMENT STRATEGIES I. NOVEM...
INTERSTITIAL
INTERSTITIAL
by lindy-dunigan
PULMONARY FIBROSIS. 1. By: . Dr.Bidhi. . Chand....
Idiopathic Pulmonary Fibrosis: Focus on Diagnostic Tools an
Idiopathic Pulmonary Fibrosis: Focus on Diagnostic Tools an
by giovanna-bartolotta
Overview of IPF. Overview of IPF (cont). The Role...
A NEW ERA in IPF:
A NEW ERA in IPF:
by pamella-moone
Trials and Treatments. Craig Thurm, MD. Director,...
Interstitial Lung Disease
Interstitial Lung Disease
by cheryl-pisano
(ILD). Mike McFarlane (CT1). 12/5/12. SLIME. What...
Case 1: Familial IPF
Case 1: Familial IPF
by jane-oiler
Case Presentation: Familial IPF. 56-year-old Hisp...
Diffuse Parynchmal Lung Disease ,How to approach?
Diffuse Parynchmal Lung Disease ,How to approach?
by pasty-toler
Dr. Abdelhaleem Bella. Assistant Professor of Med...
NAVIGATING the NEW ERA in IPF:
NAVIGATING the NEW ERA in IPF:
by min-jolicoeur
Diagnosing Idiopathic Pulmonary Fibrosis. FACULTY...
CHARLENE D. FELL, MD, MSc
CHARLENE D. FELL, MD, MSc
by pamella-moone
PULMONARY FIBROSIS MANAGEMENT STRATEGIES I. NOVEM...
Difficult Conversations:
Difficult Conversations:
by alexa-scheidler
Discussing Prognosis &. Goals of Care. Sonye ...
MANUFACTURER SURVEY GIRP-IPF STUDY 2016
MANUFACTURER SURVEY GIRP-IPF STUDY 2016
by test
DEFINITIONS USED IN SURVEY. 2. Direct-to-Pharmacy...
PILOT: Background PILOT
PILOT: Background PILOT
by 2coolprecise
(. P. ulmonary Fibrosis . I. dentification: . L. e...
Supplementary
Supplementary
by harmony
1InformationforRecapitulating idiopathic pulmonary...
Orvepitant first in category, once daily, novel treatment for Idiopathic Pulmonary Fibrosis Chroni
Orvepitant first in category, once daily, novel treatment for Idiopathic Pulmonary Fibrosis Chroni
by winnie
January 2021. Summary - orvepitant first in class/...
Please feel free to use, update, and share some or all of these slides in your noncommercial presen
Please feel free to use, update, and share some or all of these slides in your noncommercial presen
by victoria
When using our slides, please retain the source at...
Unlocking the Potential of Therapeutics
Unlocking the Potential of Therapeutics
by YouCanCallMeAl
for Fibrosis & Oncology. Corporate Presentatio...
Paolo Spagnolo Clinica di Malattie dell’Apparato Respiratorio
Paolo Spagnolo Clinica di Malattie dell’Apparato Respiratorio
by joanne
Università degli Studi di Padova. Terapia della f...
INQUINAMENTO AMBIENTALE E MALATTIE RESPIRATORIE
INQUINAMENTO AMBIENTALE E MALATTIE RESPIRATORIE
by alyssa
Sergio Harari. U.O. di Pneumologia . Ospedale San ...
Infrastructure Prioritization Framework:
Infrastructure Prioritization Framework:
by zachariah838
A tool to support the infrastructure planning proc...
Patient with IPF and no
Patient with IPF and no
by luanne-stotts
. honeycombing. on HRCT. Case 1 | Demosthenes B...
Diseases of the respiratory system lecture 5
Diseases of the respiratory system lecture 5
by karlyn-bohler
Dr. . Heyam. . Awad. FRCPath. Restrictive lung...
Infrastructure Project Finance (IPF) Guidelines
Infrastructure Project Finance (IPF) Guidelines
by karlyn-bohler
Infrastructure Project Finance (IPF) Guidelines an...
NOVEL
NOVEL
by tatyana-admore
TARGETS FOR THE FUTURE: WHAT’S PROMISING. ? . A...
Usual interstitial pneumonia (UIP),
Usual interstitial pneumonia (UIP),
by kittie-lecroy
Honeycombing, and Traction bronchiectasis: . Rad-...
Interstitial Lung Disease
Interstitial Lung Disease
by olivia-moreira
Anne McKay. Consultant Respiratory Physician. Que...
Novel indica�ons
Novel indica�ons
by stefany-barnette
Idiopathic Pulmonary Fibrosis (IPF) Hams et al. ...
Mat erial s makes on e ous heetS eodS xS dfS VS CiS BC or STnjn nS eoutdoorS radefS plyw ood On pi eS VS xS oV VS fi nishedfS dS pin efurr in gS str ipf om oS mS exteri orjg ra de scr ew siS nVS On pi
Mat erial s makes on e ous heetS eodS xS dfS VS CiS BC or STnjn nS eoutdoorS radefS plyw ood On pi eS VS xS oV VS fi nishedfS dS pin efurr in gS str ipf om oS mS exteri orjg ra de scr ew siS nVS On pi
by ellena-manuel
batcatalogcom 57513 cop yr ight Bat Conser vation ...
Asbestos Exposure
Asbestos Exposure
by tawny-fly
Frans Naude. Asbestos Exposure. Inhalation of asb...